Two cornea and refractive specialists discussed the most common reasons an IOL exchange may be needed and the initial diagnostic steps to rule out other reasons for poor quality vision. They shared pearls for performing these cases and the importance of having a comprehensive plan of attack.
For years, ophthalmologists had limited prescription options for patients with ocular surface disease. In the last decade, the number of available options has grown with several receiving approval in 2023. Two experts shared their thoughts and experiences with these new options.
Genetic testing for glaucoma is not quite ready for “primetime,” but it’s close. Two physicians provided their thoughts on the current state of glaucoma genetic testing, its potential utility for patients, and what’s on the wish list.
Whether it’s no-shows, cancellations, or follow-up care, missed appointments can cost money, create a revolving patient base, waste valuable staff time, and reduce the effectiveness of care. Here are a few ways you can improve scheduling and boost your bottom line.
The Scheie Eye Institute residents reviewed “Visual outcome and postoperative complications of cataract surgery in patients with ocular surface disorders” from the Journal of Cataract & Refractive Surgery.
In her introduction, Karolinne Rocha, MD, PhD, previewed the articles in the Refractive section and specifically shared some thoughts on the trends that may be causing a decline in LASIK procedures.
“As we continue to see progress in ocular surface therapeutics, we need to continue to evolve our vocabulary surrounding ocular surface disease. I challenge you to start differentiating your ‘dry eye’ patients as you see them in clinic,” said Cornea Editor Julie Schallhorn, MD. Read her introduction to the Cornea section for more details.
This year’s Operation Sight Volunteer of the Year is Andrew Kao, MD. Dr. Kao was recognized during the 2024 ASCRS Annual Meeting. Dr. Kao is also part of a nonprofit in Bakersfield, California, called the Advanced Center for Eyecare, whose mission is to serve the underserved and underinsured.
Since its approval, femtosecond laser-assisted cataract surgery (FLACS) has divided cataract surgeons into frequent users of the technology and those who do not think that it brings value to their practice. EyeWorld spoke with two surgeons who say they consistently benefit from FLACS in their practice.
The future of corneal refractive surgery is in the works. EyeWorld checked in on various technologies in the pipeline with physicians in the know.